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RESEARCH LETTER
Nod-Like Receptor
Pyrin-Containing Protein
6 (NLRP6) Is Up-regulated
in Ileal Crohn’s Disease
and Differentially Expressed
in Goblet Cells
A contributing factor in the develop-
ment of ulcerative colitis (UC) and
Crohn’s disease (CD) is aberrant
signaling of the innate immunecomplex known as the inﬂammasome.
The inﬂammasome regulates the pro-
duction of interleukin (IL)1b and
drives downstream inﬂammatory
pathways. In this study of human tis-
sue (ethics approval: H11930), we
provide evidence for the disease-
speciﬁc up-regulation of NLRP6 tran-
script and protein in ileal CD and
describe an NLRP6-expressing goblet
cell (GC) located predominantly in the
upper portion of the intestinal crypt.
Patient demographic details are pro-
vided in Supplementary Table 1.By using paired quiescent and active
biopsy specimens from UC and CD
patients we found that the expression of
NLRP6 increasedwithdisease activity. In
ileal CD we report a 131-fold (P < .001)
increase in NLRP6 expression compared
with a 3.9-fold (P ¼ .03) increase in
colonic CD (Figure 1A). The increase in
IL1b expression was concomitant with
increasedmessengerRNA levels of other
inﬂammasome-related genes such as
NLRP1, NLRP3, NLRC4, NLRP12, and
AIM2 (Figure 1B and Supplementary
Figure 1A and B), suggesting IL1bFigure 1. The effect of
disease activity and rosi-
glitazone treatment on
the expression of NLRP6-
related genes. (A–D)
Paired colon biopsy spec-
imens from quiescent (q)
and active disease (a) in
ileal CD (n ¼ 6), colonic CD
(n ¼ 9), and UC patients
(n ¼ 30). Relative gene
expression of individual
biopsy specimens
expressed as log10-fold
change. Horizontal lines
indicate the median rela-
tive expression and error
bars represent the inter-
quartile ranges. (E and F)
Gene expression of NLRP6
and MUC2 in LS174T cells
treated with rosiglitazone
(5–50,000 nmol/L). Levels
are relative to ethanol-
treated control cells. Data
are expressed as means ±
SEM of 3 independent ex-
periments performed in
duplicate. The signiﬁcance
threshold was P < .05. Un,
unstimulated.
Figure 2. The differential
NLRP6 expression in ileal
CD goblet cells and over-
lap of NLRP6/E-cadherin
ﬂuorescence signals.
Representative immuno-
ﬂuorescence confocal im-
ages of NLRP6 (magenta),
MUC2 (green), in (A) active
ileal CD colon biopsy
specimens and (B) normal
colon biopsy specimens.
Solid line indicates goblet
cells with high NLRP6
expression. Dashed line
indicates goblet cell
with minimal NLRP6
expression. Representa-
tive immunoﬂuorescence
confocal images of NLRP6
(magenta) and E-cadherin
(green) in (B) active ileal
CD biopsy specimens
and (D) normal colon
biopsy specimens. Spatial
proﬁling is indicated by the
straight dotted line. Nuclei
were stained with 4’,6-
diamidino-2-phenylindole
(DAPI, blue), original
magniﬁcation for all
images: 400. Scale bars:
50 mm. Ecad, E-cadherin.
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is not solely NLRP6-dependent.
Interestingly, the expression of IL18
remained constant despite variations
in NLRP6 expression (Figure 1C).
Mouse models have indicateddiscrepancies regarding the associa-
tion of NLRP6 with the production of
IL18. For example, Nlrp6 deﬁciency
has been associated with low levels
of IL181 and the induction of
intestinal IL18 has been shown to beNLRP6-dependent.2 However, Nor-
mand et al3 reported no NLRP6-
dependent changes in the transcript
abundance of IL18 in tumoral and
nontumoral biopsy specimens pro-
cured from Nlrp6þ/þ and Nlrp6-/-
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et al,3 this study reports no change in
the expression of IL18 despite localized
NLRP6 expression in inﬂamed human
CD or UC biopsy tissue, suggesting IL18
expression is not NLRP6-dependent.
NLRP6 was found to be highly
expressed in colon biopsy specimens
from active ileal CD patients and
localized to the epithelial cell layer,
myoﬁbroblasts, neutrophils, and
monocytic lineage cells of the lamina
propria (Supplementary Figure 2).
Previously, NLRP6 expression in the
normal human gut has been described
as restricted to the duodenum,
jejunum/ileum, and absent from the
colon.4 In contrast, murine Nlrp6 is
highly expressed in the small and large
intestine.3
In mice, Nlrp6 has been shown to
regulate goblet cell mucin production
and secretion,5,6 and direct self-
renewal and proliferation of epithelial
cells.3 By using immunoﬂuorescence
confocal microscopy we sort to ascer-
tain the spatial relationship of NLRP6
to the major mucin protein MUC2 and
the epithelial cell marker E-cadherin.
The ﬂuorescence signal of NLRP6 was
not present in the MUC2 granules
(Figure 2A and C), but overlapped the
ﬂuorescence signal of E-cadherin
(Figure 2B and D). Both myoﬁbroblasts
and E-cadherin contribute to epithelial
cell structure and renewal. Colonic
myoﬁbroblasts are a major source of
modulators of the Wnt signaling
pathway, which governs approximately
80 genes involved in the differentia-
tion, proliferation, and upward migra-
tion of gastrointestinal epithelial cells.
Cellular adhesion, maturation, and the
correct placement of Paneth and goblet
cells is dependent on the proper
expression of E-cadherin.7 Given the
high expression of NLRP6 in colonic
myoﬁbroblasts and the tight associa-
tion with E-cadherin, one can speculate
that NLRP6 may play a role in epithe-
lial cell positioning and migration.
In active ileal CD biopsy specimens,
prominent NLRP6 expression was
observed in a number of upper crypt
GCs whereas other GCs remained
NLRP6 negative (Figure 2A). In the
murine system, Birchenough et al6
identiﬁed a sentinel goblet cell local-
ized to the crypt opening thatundergoes expulsion and compound
exocytosis in an NLRP6-dependent
manner. The expelled sentinel goblet
cell triggered an intercellular signal via
gap junctions that increased cyto-
plasmic Ca2þ and induced Muc2
secretion in adjacent responsive goblet
cells. Interestingly, we found the pro-
duction of MUC2 to be increased in
active ileal CD and reduced in active
UC (Supplementary Figures 2 and 3).
Transcriptional regulation of
NLRP6 by peroxisome proliferator-
activated receptor-g (PPAR-g) has
been proposed based on the presence
of binding sites for PPAR-g and reti-
noid X receptor upstream of the pro-
motor region of NLRP6.8,9 We found
the expression of PPAR-g to be
reduced in active UC and CD
(Figure 1D), and that exposure of
LS174T colonic epithelial cells to the
PPAR-g agonist rosiglitazone induced
NLRP6 but repressed MUC2 expression
(Figure 1E and F). Previously, the
expression of PPAR-g has been
reported as reduced in active UC and
comparable with normal colon in
active CD.10 Taken altogether, our
results suggest that MUC2 expression
is independent of NLRP6 activity,
however, there is insufﬁcient evidence
to suggest the negative regulation of
NLRP6 by PPAR-g.
This study has been instrumental
in highlighting inconsistencies in
NLRP6 expression, IL18 processing,
and MUC2 expression between murine
models of chemically induced colitis
and human inﬂammatory bowel dis-
ease. NLRP6 now can be regarded as
an additional diagnostic tool for dis-
tinguishing ileal CD from colonic CD
and terminal ileum involved UC.
Future work needs to address if there
is a therapeutic beneﬁt in switching on
NLRP6 in active UC or if disabling
NLRP6 improves disease activity in
ileal CD.
NICOLE RANSON,1 MARK VELDHUIS,2,3
BRENT MITCHELL,2,3
SCOTT FANNING,2,3 ANTHONY L. COOK,4
DALE KUNDE,1 RAJARAMAN ERI,1
1School of Health Sciences
4Wicking Dementia Research and
Education Centre, Faculty of Health,
University of Tasmania, Launceston,
Tasmania, Australia2Launceston General Hospital,
Launceston, Tasmania, Australia
3St Vincent’s Hospital, Calvary Health
Care, Launceston, Tasmania, Australia
Corresponding author: e-mail: rderi@
utas.edu.au.References
1. Elinav E, et al. Cell 2011;
145:745–757.
2. Levy M, et al. Cell 2015;
163:1428–1443.
3. Normand S, et al. Proc Natl Acad
Sci U S A 2011;108:9601–9606.
4. Gremel G, et al. J Gastroenterol
2015;50:46–57.
5. Wlodarska M, et al. Cell 2014;
156:1045–1059.
6. Birchenough GM, et al. Science
2016;352:1535–1542.
7. Schneider MR, et al. PLoS One
2010;5:e14325.
8. Levy M, et al. Trends Immunol
2017;38:248–260.
9. Kempster SL, et al. Am J Physiol
Gastrointest Liver Physiol 2011;
300:G253–G263.
10. Dou X, et al. Oncol Lett 2015;
10:1259–1266.
Abbreviations used in this letter: CD,
Crohn’s disease; GC, goblet cell; IL,
interleukin; PPAR, peroxisome proliferator-
activated receptor; UC, ulcerative colitis.
Most current article
© 2018 The Authors. Published by Elsevier
Inc. on behalf of the AGA Institute. This is
an open access article under the CC BY-
NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).
2352-345X
https://doi.org/10.1016/j.jcmgh.2018.03.001Received November 22, 2017. Accepted March
5, 2018.
Author contributions
Nicole Ranson, Anthony Cook, and Rajaraman Eri
conceived and designed the experiments; Nicole
Ranson performed laboratory analyses and wrote
the manuscript; Brent Mitchell, Scott Fanning,
and Mark Veldhuis collected biopsy samples;
Dale Kunde analyzed RNA sequencing data; and
all authors critically reviewed the manuscript
before submission.
Conﬂicts of interest
The authors disclose no conﬂicts.
Funding
This project was supported by the Clifford Craig
Medical Research Trust, Launceston, Tasmania,
Australia. An Australian Government Research
Training Program Scholarship also provided
student support.
2018 NLRP6 in Ileal CD and Goblet Cells 112.e1Supplementary Materials
and Methods
Ethics
The study was conducted by the
University of Tasmania, in collabora-
tion with local gastroenterologists, St
Vincent’s Private Hospital, and Laun-
ceston General Hospital. Human ethics
was approved by the University of
Tasmania (ethics approval: H11930).
All participant in this study provided
informed written consent or parental
consent and were between ages 15 and
80 years. All authors had access to the
study data and reviewed and approved
the ﬁnal manuscript.
Study Participants and Biopsy
Collection
A total of 85 patients presenting for
routine colonoscopy investigations
between June 2012 and June 2014
were recruited for this study. Inﬂam-
matory bowel disease patients were
excluded if they were experiencing
co-existing irritable bowel syndrome
or non–inﬂammatory bowel disease–
associated gastrointestinal bleeding at
the time of colonoscopy. Inﬂammatory
bowel disease patients had paired
colonic biopsy specimens taken from
both inﬂamed mucosa and non-
inﬂamed mucosa. Control patients
were excluded if they had a previous
history of inﬂammatory bowel disease
or irritable bowel syndrome.
Of the 85 participants, 30 UC
patients and 15 CD patients had
colonic biopsy specimens taken from
both inﬂamed mucosa and non-
inﬂamed mucosa. Ten UC patients and
4 CD patients were in remission at the
time of colonoscopy and only had
biopsy specimens taken from non-
inﬂamed mucosa. Four UC and 2 CD
patients presented with colonic dis-
ease in its entirety and had biopsy
specimens taken from only inﬂamed
mucosa. Twenty control patients had
biopsy specimens collected from
healthy noninﬂamed mucosa.
Disease assessment and biopsy
location was at the discretion of the
treating gastroenterologist (M.V., B.M.,
and S.F.). Selection for immunohisto-
chemistry or immunoﬂuorescence
microscopy analysis was based on
patient pathology reports and onlybiopsy specimens from the descending
left colon with active disease features
were chosen.
Cell Culture
The human colorectal adenocarcinoma
cell line, LS174T, was obtained from
Sigma-Aldrich, Corp (St. Louis, MO),
and cultured in RPMI Medium 1640
(Gibco, Gaithersburg, MD) supple-
mented with 10% fetal bovine serum
(Life Technologies, Carlsbad, CA),
GlutaMAX (Life Technologies), and
1% penicillin/streptomycin (Cellgro,
Corning Life Sciences, Tewksbury, MA).
Cells were maintained in a 37C incu-
bator with 5% CO2 and a relative
humidity of 95%. Cells between
passages 6–10 were seeded at 1.2 
105/cm2 1 day before a 6-hour incuba-
tion with varying concentrations of
rosiglitazone1 (chemical abstract service
number: 122320-73-4; Sigma-Aldrich
Corp). Experiments were performed in
duplicate on 3 separate occasions.
Gene Expression Analysis
Total RNA was extracted from tissue
biopsy specimens and LS174T cells
using the RNeasy Plus Mini Kit (Qia-
gen, Venlo, The Netherlands). RNA
quality and concentration were deter-
mined using the Experion automated
electrophoresis system (Bio-Rad,
Hercules, CA). RNA was reverse-
transcribed to complementary DNA
using the iScript complementary DNA
synthesis kit (Bio-Rad). Quantitative
real-time polymerase chain reaction
was performed on a StepOne analyzer
(Applied Biosystems, CA) using a
TaqMan Universal PCR Master mix
(Applied Biosystems, Foster City, CA)
and on-demand gene-speciﬁc primers
for human NLRP6, IL1b, and IL18. Gene
expression was quantiﬁed using the
comparative (delta-delta CT) method in
which the threshold cycle was normal-
ized to the reference gene, eukaryotic
translation elongation factor (EEF2).
Transcriptional Proﬁling Using
RNA Sequencing
Total RNA was extracted from
quiescent and active disease colon
biopsy specimens using the RNeasy
Plus Mini Kit (Qiagen). RNA quality and
concentration were determined using
the Agilent 2100 Bioanalyzer system(Agilent, Santa Clara, CA). Library
preparation was performed using the
SureSelect targeted RNA capture
kit (Integrated Sciences, Sydney,
Australia). Libraries were validated on
an Illumina HiSeq 2000 Sequencer (v2
100-bp pair-end reads) (Illumina, San
Diego, CA) at a concentration of 80 Mb.
Base-calling was performed ofﬂine
using Galaxy (https://galaxyproject.org).
Immunohistochemistry
Analysis
Immunohistochemistry was performed
on 10% (vol/vol) formalin-ﬁxed,
parafﬁn-embedded, left colon biopsy
specimens. Sections were deparafﬁ-
nized and subjected to 0.01 mol/L cit-
rate buffer (pH 6.0) antigen retrieval at
121C for 4 minutes in a decloaking
chamber. Endogenous peroxidases
were quenched by a 5-minute incuba-
tion in 10% H2O2 in methanol.
Nonspeciﬁc binding was blocked by a
20-minute incubation in Biocare back-
ground Sniper solution (BS966G; Bio-
care, Concord, CA). Immunostaining
was performed using speciﬁc anti-
bodies against NLRP6 (NBP2-31372;
Novus Biologicals, Littleton, CA) and
MUC2 (H:300 sc-15334; Santa Cruz
Biotechnologies, Dallas, TX) at
room temperature for 1 hour. Samples
were incubated with a horseradish
peroxidase polymer (MRH53BL10;
Biocare) for 30 minutes, stained with
Betazoid 3,30-diaminobenzidine tetra
hydrochloride chromogen (BDB900B;
Biocare), counterstained with hema-
toxylin, dehydrated, and mounted with
distyrene, plasticizer, and xylene
mounting media. Slides were examined
using an IX71 microscope (Olympus
Australia, Melbourne, Australia).
Confocal Immunoﬂuorescence
Microscopy
Immunoﬂuorescence staining was
performed on 10% vol/vol formalin-
ﬁxed, parafﬁn-embedded, left colon
biopsy specimens. Sections were
deparafﬁnized and subjected to 0.01
mol/L citrate buffer (pH 6.0) antigen
retrieval at 121C for 4 minutes in a
decloaking chamber. Nonspeciﬁc bind-
ing was blocked by a 1-hour incubation
in blocking buffer (0.1 mol/L
phosphate-buffered saline/5% normal
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temperature in the dark. Immunoﬂuo-
rescence staining was performed using
speciﬁc antibodies against NLRP6
(NBP2-31372; Novus Biologicals),
MUC2 (H:300 sc-15334 and F-2: sc-
515032l; Santa Cruz Biotechnologies),
and E-cadherin (NCH-38, M3612; Dako
North America, CA) in the dark, at
room temperature for 1 hour or alter-
natively overnight at 4C. Sections then
were incubated for 1 hour in the dark
with 1 or more Alexa Fluor–conjugated
secondary antibodies (Cell Signalling
Technology, Danvers, MA). Section
were incubated with Hoechst 33342
(62249; ThermoFisher Scientiﬁc,
Waltham, MA) diluted in phosphate-
buffered saline and mounted with
ProLong Gold Antifade (P36930;
ThermoFisher Scientiﬁc). Slides were
examined using a FV1200 Laser Scan-
ning Confocal Inverted Microscope
(Olympus Australia).Data Analysis
Analysis of quantitative real-time
polymerase chain reaction data
from colon biopsy specimens and
rosiglitazone-treated LS174T cells was
performed using Microsoft Excel and
GraphPad Prism software (version 7.0;
GraphPad Software, Inc, La Jolla, CA).
Colon biopsy gene expression was
compared with a healthy control group
and normalized to the housekeeping
gene EEF2. Group differences were
tested using paired t tests of log10-
transformed data. Data are presented
as median relative expression and
interquartile ranges. Differences be-
tween group means for LS174T cells
was assessed using 1-way analysis of
variance and data are presented as
means ± SEM.
Analysis of immunohistochemistry
data and spatial intensity proﬁling was
performed using the FIJI version
(Dec 2009) of ImageJ software(http://imagej.nih.gov/ij/downloads.html,
ImageJ, US National Institutes ofHealth,
Bethesda, MD), and GraphPad Prism
(version 7; GraphPad Software, Inc).
Group differences and statistical signif-
icance were evaluated using a 1-way
analysis of variance followed by Dun-
nett’s multiple comparison test. Data are
presented as means ± SD. In all pre-
sented data the signiﬁcance threshold
was set at P < .05.References
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Supplementary
Figure 1. Targeted RNA-
sequencing analysis of
inﬂammasome-related genes
in CD biopsy specimens. (A)
Targeted RNA-sequencing anal-
ysis of ileal CD biopsy specimens
(n ¼ 4) during active disease.
Gene expression results are
expressed as log 2 (fold change),
normalized to housekeeping
genes and relative to a normal
control group (n ¼ 4), which is
indicated by the dotted vertical
line. Up-regulated genes are
shown as magenta, down-
regulated genes are shown as
black. (B) Targeted RNA-
sequencing analysis of colonic
CD biopsy specimens (n ¼ 4)
during active disease. Gene
expression results are expressed
as log 2 (fold change), normalized
to housekeeping genes and rela-
tive to a normal control group
(n ¼ 4), which is indicated by the
dotted vertical line. Up-regulated
genes are shown as magenta,
down-regulated genes are shown
as black. NOD, nucleotide-
binding oligomerization domain
containing.
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Supplementary Figure 2. (See previous page). Representative immunohistochemistry (IHC) images and quantiﬁcation
of NLRP6 and MUC2 expression in left colon biopsies. All biopsies were parafﬁn embedded, cut into 3-5 mm sections and
incubated with NLRP6 (NBP2-31372, Novus Biologicals, Littleton, CA) and MUC2 (H:300 sc-15334, Santa Cruz Bio-
technologies, TX). Images were captured using DP21 microscope camera (Olympus Australia, Melbourne, Australia) attached
to an IX71 microscope (Olympus). Images are 400X and scale bar ¼ 50 mm. (A) Quantitative (Quant.) analysis of DAB staining in
parafﬁn embedded left colon mucosal biopsies as analysed by IHC. (B) NLRP6 expression in sections from normal colon
(number of images analysed ¼ 18), active UC (n ¼ 43), remission UC (Rem. UC, n ¼ 20), active ileal CD (n ¼ 34), active colonic
CD (n ¼ 18) and remission CD (Rem. CD, n ¼ 12). (C) MUC2 expression in sections from normal colon (n ¼ 20), active UC n ¼
62), remission UC (n ¼ 20), active ileal CD (n ¼ 24), active colonic CD (n ¼ 30), and remission CD (n ¼ 30). The optical intensity
of DAB staining was determined using ImageJ software. All data are presented as mean ± standard deviation. Statistical
signiﬁcance was evaluated using Dunn’s multiple comparison One-way ANOVA and the signiﬁcance threshold was P < .05.
Here we present contrasting expression patterns for both NLRP6 and MUC2. In active ileal CD, NLRP6 expression is localised
to the epithelial cell layer, myoﬁbroblasts, neutrophils and monocytic linage cells residing in the lamina propria. In active UC
NLRP6 expression is limited to lamina propria immune cells and absent for the epithelial cell layer. Interestingly, in the normal
colon, moderate cytoplasmic NLRP6 expression was present in the epithelial cell layer and scattered within the lamina propria
cells. Quantitative analysis of NLRP6 IHC staining conﬁrms the high NLRP6 expression observed in ileal CD (active ileal CD vs
active colonic CD, P < .001; active ileal CD vs remission CD, P < .001). MUC2 expression in active IBD and the normal colon is
highly variable in distribution and depth. In active CD, both colonic and ileal the expression of MUC2 is increased while in UC it
is reduced. The reduced MUC2 expression in active UC is well established and consistent with previous studies in human
derived material.[2-4] Interestingly, there was no change in MUC2 expression in ileal and colonic CD despite the increased
NLRP6 in ileal CD. Quantitatively, the expression of MUC2 in active ileal CD was greater than in active UC (P ¼ .002).
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Supplementary Figure 3. Representative immunoﬂuorescence images of MUC2 localization in normal colon, active UC,
and active ileal and colonic CD. All biopsy specimens were taken from the left colon, parafﬁn-embedded, cut into 5-mm
sections, incubated with MUC2 (H:300: sc15334, 1:200 dilution; Santa Cruz), and visualized using Alexa Fluor 647–conjugated
goat anti-rabbit IgG (green). Nuclei were stained with Hoechst 33342 (40,6-diamidino-2-phenylindole, blue). Scale bars: 100 mm
for both the 100 and 400 magniﬁcation. Here, we present immunoﬂuorescence microscopy images showing the variations
in MUC2 architecture. In CD, the MUC2 granules are highly organized and this structural organization is lacking in active UC
and in the normal colon. Furthermore, colonic crypts normally contain smaller goblet cell theca containing less MUC2 in the
lower crypts and larger MUC2-ﬁlled theca in the upper crypt.5 However, in active ileal CD and active colonic CD we observed
large tightly packed theca containing MUC2 granules along the entire crypt length, and the overcrowding of goblet cells often
was associated with crypt distortion.
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Supplementary Table 1.Demographic Data for Study Participants
Patient category Patients, n Age, y Sex
Disease
duration, y
Control patients 20 57 ± 14 11 F, 9 M -
Paired UCa 30 50 ± 18 16 F, 14 M 11 ± 12
Quiescent UC only 10 49 ± 11 6 F, 4 M 15 ± 11
Active UC only 4 39 ± 21 2 F, 2 M 11 ± 13
Paired ileal CDa 6 41 ± 16 2 F, 4 M 12 ± 8
Active ileal CD only 1 28 1 M 15
Paired colonic CDa 9 46 ± 15 4 F, 5 M 8 ± 4
Active colonic CD only 1 46 1 F 11
Quiescent CD (includes ileal
CD and colonic CD) only
4 20 ± 7 3 F, 1 M 9 ± 14
NOTE. All data are shown as means ± SD. The disease duration at the time of
biopsy is shown for each group as the mean value ± SD. The average onset of
disease can be calculated by subtracting the disease duration from the average
age of the patient. Inﬂammatory bowel disease patients comprised 65 of the total
85 participants, and, of these, 35 were women and 30 were men. The mean age of
inﬂammatory bowel disease patients providing paired biopsy specimens was
slightly younger for the CD group (44 ± 16 y) than the UC group (50 ± 18 y). The
mean age of the control group was 57 ± 14 years and comprised 11 women and 9
men.
F, females; M, males.
aPatients had biopsy specimens taken from quiescent disease and active disease
regions.
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